Tisch MS News

For those of you who missed the original broadcast, Dr. Sadiq's segment on The Dr. Oz show is available on The Dr. Oz Show website: here (part 1) and here (part 2) .

December 13, 2013

More

For those of you who missed the original broadcast, Dr. Sadiq's segment on The Dr. Oz show is available on The Dr. Oz Show website: here (part 1) and here (part 2) .

December 11, 2013

More

Tune in to The Dr. Oz Show this Thursday, December 12th to see Dr. Sadiq as a featured guest along with his patient Richard Cohen and Richard's spouse Meredith Vieira. Richard and Meredith will be discussing living with MS and their hopes for our recently approved FDA Phase I Stem Cell Clinical...

December 10, 2013

More

Dr. Steven A. Goldman, MD, PhD, Co-Director of the Center for Translational Medicine and Professor in the Departments of Neurology and Neurosurgery at the University of Rochester School of Medicine and Dentistry, delivered the Grand Rounds lecture for December 4, 2013. Dr. Goldman's presentation...

December 4, 2013

More

Tisch MS Research Center of New York would like to advise patients and other interested parties that we will be closing at 2pm on Wednesday, November 27, and reopening on Monday, December 2, in observance of the Thanksgiving holiday.

November 22, 2013

More

Tisch MSRCNY welcomed almost 1,000 guests on Sunday, October 13, 2013 to the New York Hilton. We would like to thank our patients and supporters for making this a truly momentous event! The title of Dr. Sadiq’s talk, “What Does This Study Mean For Me?” signified an opportunity to answer many...

October 17, 2013

More

Multiple Sclerosis Journal has selected the recent Tisch MS publication " Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis ," co-authored by Violaine Harris, PhD, and Saud Sadiq, MD, among others, as its cover article for October 2013. This important biomarker discovery is...

September 24, 2013

More

Ricki Lewis, Ph.D., filed a report for the Multiple Sclerosis Discovery Forum on FDA approval for the upcoming clinical trial of MSC-NPs at the Tisch MS Research Center of New York. Lewis quotes multiple outside experts alongside Saud Sadiq, M.D., director of Tisch MS, on the science behind the...

September 16, 2013

More

The stem cell research division of the Tisch MS Research Center of New York proudly announces Food and Drug Administration (FDA) approval of autologous, mesenchymal stem cell-derived neural progenitor cells (MSC-NPs) as an Investigational New Drug (IND) for an open label, phase I clinical trial in...

August 14, 2013

More

A Research team lead by Violaine Harris, Ph.D., at the Tisch MS Research Center of New York, has just published findings on a new method of measuring disease activity in patients with multiple sclerosis (MS) (Harris, et al, Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis,...

July 26, 2013

More

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Look for the IFF Building on the North side of 57th Street across from the CBS building

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.